Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) is now available.
KPC Pharmaceuticals, partly owned by China Resources Pharmaceutical Group Ltd., has reported its unaudited preliminary financial results for the year ending December 31, 2024. The company showed a slight decrease in total operating revenue by 0.34% compared to the previous year, while experiencing significant growth in operating profit by 17.46% and net profit attributable to shareholders by 19.86%. This performance indicates stronger profitability despite stable revenue figures, which could positively impact China Resources Pharmaceutical Group’s financial outlook.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. is engaged in the pharmaceutical industry, focusing on the production and distribution of medical and pharmaceutical products. It holds a significant equity interest in KPC Pharmaceuticals, Inc., a company listed on the Shanghai Stock Exchange.
YTD Price Performance: -6.62%
Average Trading Volume: 2,178
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €4.12B
Learn more about 3320 stock on TipRanks’ Stock Analysis page.
